The webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. Webcasts will also be archived for a minimum of thirty days.

In a report released today, James Kammert from Evercore ISI maintained a Hold rating on Alexandria Equities (ARE – Research Report), with a ...

Even as the United States pursues a tougher trade policy towards China, the latest indication being the tightening of export ...

A slowdown early in Q4 led to a very conservative upgrade in the retailer’s expectations. Meanwhile, there is still no update ...

Mark Mahaney, Evercore ISI head of internet research, joins 'Squawk Box' to discuss the latest market trends, state of ...

The Wisconsin-based company reported a same-store sales decline of 9.3% – its eleventh same-store sales decline in a row.

In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...

"While we heard from many retailers last week about quarter to date accelerations, we don't think an abrupt CEO departure is ...

Kohl’s surprise CEO departure announcement a day before its quarterly results will play on the minds of investors, who were ...

ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Evercore ISI upgraded Zoom Video (ZM) to Outperform from In Line with a price target of $115, up from $70. The company ...